Gharpure VS et al. |
Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:8547871
|
Koch K et al. |
CP-123,369: a potent, orally active immunosuppressive agent. |
1995 |
Inflamm. Res. |
pmid:8548388
|
Lionetti P et al. |
Mucosal adaptation and destruction in response to lamina propria T cell activation in explants of human fetal intestine. |
1995 |
Adv. Exp. Med. Biol. |
pmid:8525974
|
Ku YM et al. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. |
1995 |
Am J Health Syst Pharm |
pmid:8528874
|
Braun W et al. |
Three-dimensional structure and actions of immunosuppressants and their immunophilins. |
1995 |
FASEB J. |
pmid:7529736
|
Venkataraman L et al. |
FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. |
1995 |
J. Exp. Med. |
pmid:7532676
|
Zarnt T et al. |
Time-dependent inhibition of peptidylprolyl cis-trans-isomerases by FK506 is probably due to cis-trans isomerization of the inhibitor's imide bond. |
1995 |
Biochem. J. |
pmid:7529995
|
Wang CR et al. |
T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. |
1995 |
J. Exp. Med. |
pmid:7532685
|
Cao W et al. |
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. |
1995 |
Transplantation |
pmid:7532879
|
Van Thiel DH et al. |
Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. |
1995 |
Am. J. Gastroenterol. |
pmid:7532912
|
Barkholt LM et al. |
New criteria for diagnosing cytomegalovirus hepatitis in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533375
|
Jusko WJ et al. |
Consensus document: therapeutic monitoring of tacrolimus (FK-506). |
1995 |
Ther Drug Monit |
pmid:8588229
|
Teraoka S et al. |
Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation. |
1995 |
Transplant. Proc. |
pmid:7533381
|
Lohse DL et al. |
Insights derived from the structures of the Ser/Thr phosphatases calcineurin and protein phosphatase 1. |
1995 |
Structure |
pmid:8590008
|
Fay JW et al. |
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation. |
1995 |
Transplant. Proc. |
pmid:7533383
|
Murase N et al. |
Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. |
1995 |
Transplant. Proc. |
pmid:7533386
|
Zeevi A et al. |
Serial evaluation of immune profiles of simultaneous bone marrow and whole organ transplant recipients. |
1995 |
Transplant. Proc. |
pmid:7533388
|
Ochiai T et al. |
Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533435
|
Scantlebury VP et al. |
Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. |
1995 |
Transplant. Proc. |
pmid:7533436
|
Hanafusa T et al. |
Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C. |
1995 |
Transplant. Proc. |
pmid:7533440
|
Bundick RV et al. |
The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response--an in vivo model of Th2-like activity. |
1995 |
Clin. Exp. Immunol. |
pmid:7533681
|
Hirakata Y et al. |
Influence of various immunosuppressive agents on the occurrence of endogenous bacteraemia in mice. |
1995 |
J. Med. Microbiol. |
pmid:7533840
|
Tumlin JA et al. |
Expression of calcineurin activity and alpha-subunit isoforms in specific segments of the rat nephron. |
1995 |
Am. J. Physiol. |
pmid:7485542
|
Furukawa F et al. |
FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. |
1995 |
Arch. Dermatol. Res. |
pmid:7487142
|
Lapa e Silva JR et al. |
Modulation of the bronchial inflammation in sensitized guinea-pigs by FK506, nedocromil sodium and dexamethasone. |
1995 |
Eur. Respir. J. |
pmid:7489798
|
Schwaninger M et al. |
Involvement of the Ca(2+)-dependent phosphatase calcineurin in gene transcription that is stimulated by cAMP through cAMP response elements. |
1995 |
J. Biol. Chem. |
pmid:7536740
|
Shackleton CR et al. |
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. |
1995 |
Transplantation |
pmid:7570950
|
Min Z and Jones NF |
Limb transplantation in rats: immunosuppression with FK-506. |
1995 |
J Hand Surg Am |
pmid:7536766
|
Lyons WE et al. |
Neuronal regeneration enhances the expression of the immunophilin FKBP-12. |
1995 |
J. Neurosci. |
pmid:7536825
|
Wortis HH et al. |
B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7536930
|
Bang H et al. |
Activation of Ca2+ signaling in neutrophils by the mast cell-released immunophilin FKBP12. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7536932
|
Canzanello VJ et al. |
Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. |
1995 |
J. Am. Soc. Nephrol. |
pmid:7542491
|
Garrett-Engele P et al. |
Calcineurin, the Ca2+/calmodulin-dependent protein phosphatase, is essential in yeast mutants with cell integrity defects and in mutants that lack a functional vacuolar H(+)-ATPase. |
1995 |
Mol. Cell. Biol. |
pmid:7542741
|
Baughman G et al. |
FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. |
1995 |
Mol. Cell. Biol. |
pmid:7542743
|
Pearlman DA and Connelly PR |
Determination of the differential effects of hydrogen bonding and water release on the binding of FK506 to native and Tyr82-->Phe82 FKBP-12 proteins using free energy simulations. |
1995 |
J. Mol. Biol. |
pmid:7538591
|
Warty V et al. |
Tacrolimus analysis: a comparison of different methods and matrices. |
1995 |
Ther Drug Monit |
pmid:7542809
|
Dumont FJ et al. |
Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. |
1995 |
Cell. Immunol. |
pmid:7538911
|
Theopold U et al. |
FKBP39, a Drosophila member of a family of proteins that bind the immunosuppressive drug FK506. |
1995 |
Gene |
pmid:7538962
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|
Firdaous I et al. |
HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients. |
1995 |
Clin. Chem. |
pmid:7544705
|
Tashiro H et al. |
Monitoring for engraftment following rat orthotopic liver transplantation by in vitro amplification of Y-chromosome gene using polymerase chain reaction. |
1995 |
Cell Transplant |
pmid:7540919
|
Ingels SC et al. |
Stability of FK506 (tacrolimus) in whole-blood specimens. |
1995 |
Clin. Chem. |
pmid:7544707
|
Hikita N et al. |
Effects of topical FK506 on endotoxin-induced uveitis (EIU) in the Lewis rat. |
1995 |
Curr. Eye Res. |
pmid:7540967
|
Cardenas ME et al. |
Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. |
1995 |
EMBO J. |
pmid:7540976
|
Madsen KL et al. |
FK506 increases permeability in rat intestine by inhibiting mitochondrial function. |
1995 |
Gastroenterology |
pmid:7540994
|
Yang WM et al. |
Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity. |
1995 |
J. Biol. Chem. |
pmid:7541038
|
Lauerma AI |
Immunomodulation of contact dermatitis. |
1995 |
Curr. Probl. Dermatol. |
pmid:7587333
|
Cardenas ME et al. |
Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. |
1995 |
Curr. Opin. Nephrol. Hypertens. |
pmid:8591053
|
Wera S et al. |
Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture. |
1995 |
Endocr. Res. |
pmid:7588431
|
Cameron AM et al. |
Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. |
1995 |
Cell |
pmid:8521476
|
Stoller G et al. |
A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor. |
1995 |
EMBO J. |
pmid:7588623
|
Tamura K |
FK506: mechanism of immunosuppression and adverse-effects. |
1995 |
J Toxicol Sci |
pmid:8531246
|
Mugiya S et al. |
Renal blood flow, fibrinolysis, and platelet aggregation following tacrolimus (FK 506) treatment in rats. |
1995 |
Thromb. Res. |
pmid:8533130
|
Kaplan A et al. |
The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes. |
1995 |
J. Dermatol. Sci. |
pmid:8534611
|
Karanam BV et al. |
FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4. |
1994 Sep-Oct |
Drug Metab. Dispos. |
pmid:7530623
|
Cacciarelli TV et al. |
Influence of the timing of FK 506 (Tacrolimus) administration on recovery of renal function from warm ischemic injury in rats. |
1994 Oct-Dec |
ASAIO J. |
pmid:7532042
|
Ryffel B et al. |
Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin. |
1994 Nov-Dec |
Exp. Nephrol. |
pmid:7532090
|
Kay AB |
Immunosuppressive agents in chronic severe asthma. |
1994 May-Jun |
Allergy Proc |
pmid:7523242
|
von Asmuth EJ et al. |
IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro. |
1994 May-Jun |
Eur. Cytokine Netw. |
pmid:7524716
|
Yoshida Y et al. |
Comparison of cardiac rejection in heart and heart-lung concordant xenotransplantation. |
1994 Mar-Apr |
J. Heart Lung Transplant. |
pmid:7518252
|
Assan R et al. |
FK 506/fluconazole interaction enhances FK 506 nephrotoxicity. |
1994 Jan-Feb |
Diabete Metab |
pmid:7520007
|
Perotti BY et al. |
FK 506 metabolism in male and female rat liver microsomes. |
1994 Jan-Feb |
Drug Metab. Dispos. |
pmid:7512020
|
Akita K et al. |
Effect of FK506 and anti-CD4 therapy on fetal pig pancreas xenografts and host lymphoid cells in nod/Lt, CBA, and BALB/c mice. |
1994 Jan-Feb |
Cell Transplant |
pmid:7512875
|
Yasunami Y et al. |
Donor-specific unresponsiveness induced by intraportal grafting and FK506 in rat islet allografts: importance of low temperature culture and transplant site on induction and maintenance. |
1994 Jan-Feb |
Cell Transplant |
pmid:7512876
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Reggiani P et al. |
Conversion to rescue therapy with FK 506: data from eight liver transplant patients. |
1994 |
Transplant. Proc. |
pmid:7527982
|
Langrehr JM et al. |
Mucosal recipient-type mononuclear repopulation and low-grade chronic rejection occur simultaneously in indefinitely surviving recipients of small bowel allografts. |
1994 |
Transpl. Int. |
pmid:7513999
|
Leach KL et al. |
A soluble binding assay for measuring 3H-FK506 binding to the hsp56 immunophilin. |
1994 |
J Immunoassay |
pmid:7530727
|
Genestier L et al. |
Cyclosporin A and FK506 inhibit activation-induced cell death in the murine WEHI-231 B cell line. |
1994 |
Cell. Immunol. |
pmid:7514101
|
Rao US and Scarborough GA |
Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein. |
1994 |
Mol. Pharmacol. |
pmid:7514263
|
Eng WK et al. |
The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth. |
1994 |
Gene |
pmid:7530227
|
Ellis D et al. |
Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. |
1994 |
Pediatr. Nephrol. |
pmid:7517171
|
Petros AM and Fesik SW |
Nuclear magnetic resonance methods for studying protein-ligand complexes. |
1994 |
Meth. Enzymol. |
pmid:7530321
|
Klintmalm GB |
FK 506: an update. |
1994 |
Clin Transplant |
pmid:7517226
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Curley RW et al. |
Stereospecific assignments of glycine in proteins by stereospecific deuteration and 15N labeling. |
1994 |
J. Biomol. NMR |
pmid:7517241
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Singh N et al. |
Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? |
1994 |
Dig. Dis. Sci. |
pmid:7506641
|
Kusne S et al. |
Infectious complications after small bowel transplantation in adults. |
1994 |
Transplant. Proc. |
pmid:7518153
|
Lee TK et al. |
Bacterial translocation and the role of postoperative selective bowel decontamination in small intestinal transplantation. |
1994 |
Transplant. Proc. |
pmid:7518154
|
Dilling MB et al. |
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. |
1994 |
Cancer Res. |
pmid:7508822
|
Yamamoto S et al. |
Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. |
1994 |
J. Invest. Dermatol. |
pmid:7508960
|
Ito T et al. |
Protective effects of gabexate mesilate on acute pancreatitis induced by tacrolimus (FK-506) in rats in which the pancreas was stimulated by caerulein. |
1994 |
J. Gastroenterol. |
pmid:7520321
|
Zeniya A et al. |
Anti-ulcer effect of FK 506, immunosuppressive agent, in rats. |
1994 |
J. Gastroenterol. |
pmid:7520322
|
Dawson TM et al. |
Nitric oxide: cellular regulation and neuronal injury. |
1994 |
Prog. Brain Res. |
pmid:7533914
|
|
Tacrolimus (FK506) for organ transplants. |
1994 |
Med Lett Drugs Ther |
pmid:7520968
|
Bierer BE |
Biology of cyclosporin A and FK506. |
1994 |
Prog. Clin. Biol. Res. |
pmid:7536944
|
Malyszko J et al. |
FK 506 affects platelet aggregation in vitro. |
1994 |
Thromb. Res. |
pmid:7521072
|
Schreier MH |
Immunophilins and immunosuppression by cyclosporins and macrolide structures. |
1994 |
Acta Derm Venereol Suppl (Stockh) |
pmid:7521103
|
Mouzaki A and Rungger D |
Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells. |
1994 |
Blood |
pmid:7522636
|
Abu-Elmagd K et al. |
Three years clinical experience with intestinal transplantation. |
1994 |
J. Am. Coll. Surg. |
pmid:7522850
|
Shapiro R et al. |
Improving results of pediatric renal transplantation. |
1994 |
J. Am. Coll. Surg. |
pmid:7522851
|
Fung JJ and Starzl TE |
FK 506 in solid organ transplantation. |
1994 |
Transplant. Proc. |
pmid:7524226
|
|
Tacrolimus introduced for use in liver transplantation. |
1994 |
Am J Hosp Pharm |
pmid:7524317
|
Przepiorka D et al. |
Blood tacrolimus concentration unchanged by plasmapheresis. |
1994 |
Am J Hosp Pharm |
pmid:7524318
|
Shaw LM and Brayman KL |
FK-506 therapeutic drug monitoring. |
1994 |
Clin. Chem. |
pmid:7527305
|
Winkler M et al. |
Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression. |
1994 |
Clin. Chem. |
pmid:7527306
|
Lewis HM |
Therapeutic progress. II: Treatment of psoriasis. |
1994 |
J Clin Pharm Ther |
pmid:7527403
|
Mori A et al. |
Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. |
1994 |
Int. Arch. Allergy Immunol. |
pmid:7512393
|
Okubo Y et al. |
Cytokine production in patients with mite-sensitive bronchial asthma. |
1994 |
Int. Arch. Allergy Immunol. |
pmid:7512395
|